Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study
Oishi, N.; Berenberg, J.; Blumenstein, B.A.; Johnson, K.; Rivkin, S.E.; Bukowski, R.M.; O'Bryan, R.M.; Stephens, R.L.; Quagliana, J.; Saiers, J.H.
Cancer Treatment Reports 71(12): 1307-1308
1987
ISSN/ISBN: 0361-5960 PMID: 3690547 Document Number: 301092
Document emailed within 1 workday
Related Documents
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528
Samal, B.; Jones, S.; Brownlee, R.W.; Morrison, F.; Hoogstraten, B.; Caoili, E.; Baker, L. 1978: Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study Cancer Treatment Reports 62(1): 19-22
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Goodwin, W.; Stephens, R.; McCracken, J.D.; Groppe, C. 1981: Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study Cancer Treatment Reports 65(3-4): 359
Ahnen, D.J.; Feigl, P.; Quan, G.; Fenoglio-Preiser, C.; Lovato, L.C.; Bunn, P.A.; Stemmerman, G.; Wells, J.D.; Macdonald, J.S.; Meyskens, F.L. 1998: Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study Cancer Research 58(6): 1149-1158
Weiss, G.B.; Metch, B.; Von Hoff, D.D.; Taylor, S.A.; Saiers, J.H. 1987: Phase Ii trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1313-1314
Leichman, L.; Steiger, Z.; Seydel, H.G.; Vaitkevicius, V.K. 1984: Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience Seminars in Oncology 11(2): 178-185
Gagliano, R.G.; Panettiere, F.J.; Haas, C.D.; Baker, L.; Hewlett, J.; Stuckey, W.J.; O'Bryan, R.M.; Bottomley, R.; Heilburn, L.K. 1981: Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. a Southwest Oncology Group study Cancer Clinical Trials 4(4): 401-405
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Hilgers, R.D.; Von Hoff, D.D.; Stephens, R.L.; Boutselis, J.G.; Rivkin, S.E. 1985: Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study Cancer Treatment Reports 69(11): 1329-1330
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R. 1982: Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study Cancer Treatment Reports 66(7): 1687-1688
Saiki, J.H.; Baker, L.H.; Stephens, R.L.; Fabian, C.J.; Kraut, E.H.; Fletcher, W.S. 1982: Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study Cancer Treatment Reports 66(8): 1673-1674
Weick, J.K.; Rainey, J.M.; Livingston, R.B.; Baker, L.H.; O'Bryan, R.M.; Chen, T.T. 1985: Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study Cancer Treatment Reports 69(6): 583-585
McCracken, J.D.; Janaki, L.M.; Taylor, S.B.; Giri, P.G.; Weiss, G.B.; Gordon, W.; Vance, R.B.; Crowley, J. 1986: Concurrent chemotherapy and radiotherapy for limited small-cell carcinoma of the lung: a Southwest Oncology Group Study Seminars in Oncology 13(3 Suppl 3: 31-36
Cowan, J.D.; Surwit, E.A.; Alberts, D.S.; Boutselis, J.G.; Neilan, B.A. 1986: Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study Cancer Treatment Reports 70(3): 423-424
Livingston, R.B.; Helibrun, L.; Lehane, D.; Costanzi, J.J.; Bottomley, R.; Palmer, R.L.; Stuckey, W.J.; Hoogstraten, B. 1977: Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group Study Cancer Treatment Reports 61(9): 1623-1629
Okamura, K.; Kinukawa, T.; Tsumura, Y.; Otani, T.; Itoh, H.; Kobayashi, H.; Matsuura, O.; Kobayashi, M.; Fukatsu, T.; Ohshima, S. 1998: A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group European Urology 33(3): 285-8; discussion 289
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740